Virtu KCG Holdings’s Biolase, Inc. BIOL Stock Holding History

Virtu KCG Holdings’s Portfolio BIOL Stock Details BIOL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$27K	Buy	+2	New	+$29.7K	﹤0.01%	2694
2017 Q1	–	Sell	-4	Closed	-$62K	–	3865
2016 Q4	$62K	Buy	4 +2	+100%	+$39.6K	﹤0.01%	3040
2016 Q3	$53K	Buy	+2	New	+$35.6K	﹤0.01%	2772
2016 Q2	–	Sell	-3	Closed	-$44K	–	3409
2016 Q1	$44K	Buy	+3	New	+$37.6K	﹤0.01%	2489
2015 Q4	–	Sell	-2	Closed	-$26K	–	4024
2015 Q3	$26K	Buy	+2	New	+$37.2K	﹤0.01%	3113
2015 Q2	–	Sell	-9	Closed	-$235K	–	3855
2015 Q1	$235K	Buy	+9	New	+$255K	﹤0.01%	2204
2014 Q2	–	Sell	-2	Closed	-$46K	–	4147
2014 Q1	$46K	Hold	2	–	–	﹤0.01%	3346
2013 Q4	$60K	Buy	+2	New	+$47.4K	﹤0.01%	3565

Other funds holding BIOL

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

GIP

Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return

TMC

Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virtu KCG Holdings's BIOL Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in Biolase, Inc. (BIOL) in Q2 2017: 2 shares worth $27K. The stake represents ﹤0.01% of the portfolio and ranks #2694 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in BIOL as recently as Q4 2016.

Virtu KCG Holdings first reported a position in BIOL in Q4 2013 and has held it in 8 quarters since. The position peaked at $235K in Q1 2015. 32 funds tracked by Wall St. Rank hold BIOL as of Q2 2017.

Virtu KCG Holdings held 2 shares of Biolase, Inc. worth $27K as of Q2 2017.
Biolase, Inc. was a new Virtu KCG Holdings position in Q2 2017.
Biolase, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2694 holding.
Virtu KCG Holdings first reported a position in Biolase, Inc. in Q4 2013 and has held it in 8 quarters since.
Virtu KCG Holdings's Biolase, Inc. position peaked at $235K in Q1 2015.
32 funds tracked by Wall St. Rank held Biolase, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.